Clinical Drug Experience Knowledgebase

apremilast (otezla) (1 trial)

empagliflozin (jardiance) (1 trial)

metformin (glucophage) (1 trial)

ornithine aspartate (1 trial)

pioglitazone (actos) (1 trial)

polyethylene glycol (1 trial)

secukinumab (cosentyx) (1 trial)

ulinastatin (1 trial)

levocarnitine (carnitor) (1 trial)

sodium chloride (1 trial)

tazarotene (tazorac) (2 trials)

tranexamic acid (cyklokapron) (1 trial)

bleomycin (blenoxane) (1 trial)

clindamycin (cleocin) (1 trial)

dapsone (aczone) (1 trial)

doxycycline (vibramycin) (1 trial)

fluocinolone acetonide (synalar) (1 trial)

fuke qianjin (1 trial)

hydroquinone (1 trial)

insulin human (humulin) (1 trial)

metronidazole (flagyl) (1 trial)

platelet-rich plasma (2 trials)

tretinoin (Retin-A) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

vitamin c (1 trial)

naltrexone (revia) (1 trial)

apigenin (1 trial)

chamomile (1 trial)

crocin (1 trial)

platelets (1 trial)

saffron (1 trial)

trichloroacetic acid (1 trial)